2-naphthol has been researched along with lovastatin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, A; Kuroda, M; Tanzawa, K; Tsujita, Y | 1 |
| Everson, GT; Panini, SR; Spencer, TA | 1 |
| Endo, A; Komagata, D; Yamashita, H | 1 |
| Kuwano, H; Nakagawa, K; Serizawa, N; Tanaka, M; Terahara, A; Tsujita, Y | 1 |
| Gayen, AK; Peffley, DM | 1 |
| Endo, A; Kuroda, M; Tanzawa, K | 2 |
7 other study(ies) available for 2-naphthol and lovastatin
| Article | Year |
|---|---|
Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Topics: Acetates; Animals; Binding, Competitive; Caprylates; Cholesterol; Fatty Acids; Gallbladder; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Kidney; Kinetics; Lactones; Liver; Lovastatin; Male; Mevalonic Acid; Mice; Naphthalenes; Naphthols; Organ Specificity; Pyrans; Rats; Sterols | 1977 |
Effects of specific inhibition of sterol biosynthesis on the uptake and utilization of low density lipoprotein cholesterol by HepG2 cells.
Topics: Cell Line; Cholesterol; Cholesterol, LDL; Chromatography, High Pressure Liquid; Humans; Liver; Lovastatin; Naphthols; Receptors, LDL; Sterols | 1991 |
Microbial conversion of compactin (ML-236B) to ML-236A.
Topics: Ascomycota; Hydrolysis; Lovastatin; Naphthalenes; Naphthols; Yeasts | 1986 |
6 alpha-Hydroxy-iso-ML-236B (6 alpha-hydroxy-iso-compactin) and ML-236A, microbial transformation products of ML-236B.
Topics: Biotransformation; Fungi; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Magnetic Resonance Spectroscopy; Mucorales; Naphthalenes; Naphthols; Species Specificity | 1983 |
Inhibition of squalene synthase but not squalene cyclase prevents mevalonate-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis at a posttranscriptional level.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cell Line; Cricetinae; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Hydroxycholesterols; Hydroxymethylglutaryl CoA Reductases; Lovastatin; Lyases; Mesocricetus; Mevalonic Acid; Naphthols; Protein Biosynthesis; RNA, Messenger; Transcription, Genetic; Tricarboxylic Acids | 1997 |
Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. 1976.
Topics: Animals; Anticholesteremic Agents; History, 20th Century; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Naphthols; Rats | 2004 |
Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity.
Topics: Animals; Anticholesteremic Agents; Enzyme Activation; Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent; Lovastatin; Microsomes, Liver; Molecular Structure; Naphthols; Penicillium; Rats | 1976 |